Diwali shagun ke shares! Angel One selects 8 stocks with up to 50% upside to Buy this Diwali. How many do you own?

As investors enter Samvat 2083, the landscape calls for selectivity rather than indiscriminate optimism. Global uncertainties, fluctuating capital flows and evolving market expectations continue to influence equity performance. In this environment, sustainable wealth creation is likely to depend less on broad-based market movements and more on identifying businesses capable of delivering…

作者
Veer Sharma
发布方
The Economic Times
发布时间
篇幅
620 字 · 3 分钟
Diwali shagun ke shares! Angel One selects 8 stocks with up to 50% upside to Buy this Diwali. How many do you own?
Benchmarks Nifty25,030.35493.75FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.96 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return19.25 % Invest NowEnter search text:Diwali shagun ke shares! Angel One selects 8 stocks with up to 50% upside to Buy this Diwali. How many do you own?Written by Veer Sharma, ETMarkets.com|Nov 07, 2026, 10:18:54 AM IST1/8

Festive Picks

As investors enter Samvat 2083, the landscape calls for selectivity rather than indiscriminate optimism. Global uncertainties, fluctuating capital flows and evolving market expectations continue to influence equity performance. In this environment, sustainable wealth creation is likely to depend less on broad-based market movements and more on identifying businesses capable of delivering consistent earnings growth. Here are 8 stocks Angel One is bullish on:

iStock2/8

ICICI Bank

Angel One has set the target price at Rs 1,800, an upside of 14.5% from current market levels. The private lender is India's second-largest private-sector bank, with a market capitalisation of about Rs 10 lakh crore and a pan-India retail, SME and corporate franchise.

Agencies3/8

Northern Arc

The brokerage has pegged the target price at Rs 330 per share, an upside of 16% from current levels. Analysts are optimistic based on 6.1x FY29E EPS of Rs 54 (about 1.0x FY29E book value; the stock trades at 4.5x). Angel One sees a score for sustained earnings compounding as lending AUM grows 20% a year to Rs 28,600 crore by FY29E and direct-to-customer lending lifts NIM towards 10%.

ANI4/8

Aarti Pharmalabs

With a target price of Rs 1,160, the brokerage forecasts an upside of 25%. Aarti Pharmalabs is India’s largest manufacturer of xanthine derivatives (caffeine and allied products), with a 15–20% global market share. It has complete backward integration across its manufacturing value chain, with minimal reliance on Chinese imports.

ETMarkets.com5/8

Shanti Gold International

With a target price of Rs 410, the brokerage predicts an upside of 50% from current levels. The analysts rate Shanti see scope for sustained volume-led compounding as new capacity (Marol and Jaipur) and new retail customers support 50–60% FY27 revenue growth.

ETMarkets.com6/8

Ratnaveer Precision Engineering

With a target price of Rs 400, the brokerage predicts an upside of 10% from current levels. “We see scope for earnings to compound as the core washer business grows and the Copper Clad Laminate project, with production from November 2026, adds a higher-margin electronics stream. Execution on the CCL ramp-up is the key swing factor.” the brokerage said.

ANI7/8

Engineers India

With a target price of Rs 320 per share, an upside of 10% from current levels. Analysts see scope for sustained earnings compounding as the mix shifts to higher-margin consultancy, backed by a Rs 14,424 crore order book and a Rs 5,000 crore FY28 revenue target.

ETMarkets.com8/8

Apollo Micro Systems

With a target price of R 475, the brokerage forecasts an upside of 15% from current levels. The order book is a record Rs 1,765 crore and H1 FY27 revenue growth was 78%, already above the 40–45% full-year guidance. “We see scope for sustained earnings compounding as the company moves up the defence value chain into explosives and integrated weapon systems,” it added.


Disclaimer: This article has been written by Veer Sharma, who is not a SEBI-registered Research Analyst or an Investment Adviser. Veer Sharma and his/her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here​

ETMarkets.comRead more onSamvat 2083stock picksfestive stocksIndian stock marketinvestment ideasequity investmentsstock recommendationsearnings growthpharmaceutical stocksjewellery stocksEnter search text:BrowseCompanies:ABCDEFGHIJKLMNOPQRSTUVWXYZ123456789
ET TV
Festive Picks
ICICI Bank
Northern Arc
Aarti Pharmalabs

内容来源

本文由Veer Sharma报道,The Economic Times于2026年11月6日首次发布。HUE Legacy Ventures 并非本文作者。

Carried in full with attribution and a link to the original. Rights remain with the publisher, who may request removal at any time.

在 economictimes.indiatimes.com 阅读 →